Life-2023-02 Esophagogastric Variceal Bleeding
Study on the efficacy of the growth inhibitors after endoscopic treatment of acute esophagogastric variceal bleeding
| Condition(s) | Acute Esophageal Variceal Hemorrhage |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | Study on the efficacy of the growth inhibitors after endoscopic treatment of acute esophagogastric variceal bleeding |
| Who can participate | Inclusion Criteria: * acute esophagogastric bleeding with hepatic cirhosis; * stable status (no active bleeding) Exclusion Criteria: * endoscopic test limitation; * previous acute esophagogastric bleeding treatment history; * ICU; * pregnant; * Immunity disabled; |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Lead sponsor | Second Affiliated Hospital, School of Medicine, Zhejiang University |
| Locations | Hanzhou, Zhejiang, China |
| Start date | 2023-08 |
| NCT ID | NCT06011980 |
| Official listing | https://clinicaltrials.gov/study/NCT06011980 |